Poultry Health Market By Drug Type (Vaccines, Feed Additives, Parasiticides, Anti-Infectives, Other Drugs), By Test Type (Laboratory Testing, Diagnostic Imaging) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Industry Outlook

The global poultry health market is expected to reach US$ 11,506.3 million by 2026, growing at a compound annual growth rate of 7.1% from 2018 to 2026. Good poultry health management is essential for poultry production since culturing a flock with the best genetic potential will not grow efficiently if they are diseased or infected. Infectious disease-causing agents spread very quickly through the flock due to high stocking densities in poultry farms. Therefore, for effective poultry health management, the basic aim is the prevention of infection or parasite onset, or discovery at an early stage, and early treatment. As the global population is consistently increasing, the demand for livestock and animal products is also correspondingly growing. Changing lifestyles and high demand for protein and lean foods have led to a growing uptake of poultry food items. The poultry health market is primarily made up of drugs and diagnostic tools used to ensure the health of poultry bred for human consumption, such as chicken, geese, ducks, and turkeys.

Market Synopsis

Vaccines are being pushed to take the lead in disease prevention.

Meat consumers are becoming increasingly concerned about food safety. Several local and international standards have been put in place for avoiding undesirable substances in food derived from different animals. Evidence is also available suggesting that chicken is the most prominent carrier of microorganisms causing food poisoning in humans. The risk of infection from salmonella and campylobacter has been posing a concern for both consumers and producers. Regulations have been formulated for preventing diseases in poultry birds, and vaccines are opined to be crucial in providing immunity from infections. The demand for poultry vaccines is also driven by growing poultry production, greater government initiatives towards livestock immunization and human wellbeing, and heightening demand for white meat. Technological evolution in vaccine manufacturing and growth in poultry healthcare spending are other prominent factors fueling the poultry vaccine market.

Introduction of DNA vaccines to shape the future roadmap of the global market

With the outbreak of critical diseases such as Newcastle disease, respiratory infections, and avian influenza, poultry farmers are increasingly opting for preventive diagnosis of their flocks. This ensures not only healthy products but also avoids catastrophic losses to farmers. Technological advancement has also resulted in the availability of previously unavailable vaccines on the market. For instance, Merck Animal Health has an active project involving the use of an electron beam to inactivate Clostridium perfringens, which will create a novel vaccine to control necrotic enteritis in flocks. In November 2017, the U.S. FDA granted approval to the first DNA vaccine by AgriLabs for controlling avian influenza. The introduction of DNA vaccines has been regarded as a watershed moment in recognizing the importance of vaccines in poultry health.DNA vaccines have a rapid response and can be manufactured faster than conventional counterparts, therefore playing a promising role during the forecast period.

Laboratory tests such as ELISA will spearhead the diagnostics space.

Disease outbreaks, supportive government policies, and technological advancements are the key factors that substantiate the pace of the poultry diagnostics market. As the incidence of critical infection outbreaks such as Newcastle disease, respiratory infections, salmonella infections, and influenza is on the rise, poultry farmers worldwide are increasingly adopting preventive measures for maintaining poultry health. Outbreaks of such diseases compromise food safety and affect the trade of birds and meat products, resulting in significant losses. As a result, continuous efforts are being undertaken to augment awareness among poultry farmers about the available preventive measures. Laboratory tests currently hold the dominant position in the poultry diagnostics segment, capturing over 50% of the market. High specificity and accuracy, and their proven ability to control epidemic outbreaks, are attributed to the dominance of this segment. Some of the prominent players in the poultry diagnostics segment are BioinGentech Biotechnology, Thermo Fisher Scientific; Bio checks Smart Veterinary Diagnostics, MEGACORP Diagnostik, IDEXX Laboratories, and others. New product development, rapid innovation in imaging technologies, and mergers and acquisitions are the key growth measures observed in the poultry diagnostics market.

North America will continue to be the leading consumer of meat products, dominating the market.

The largest regional market for poultry health is North America, followed by Asia Pacific and Europe. The prominence of North America is mainly due to its increasing domestic population, greater consumption of meat products, and increasing preference for white and lean meat as opposed to red meat. On the other hand, Asia Pacific will witness swift growth during the forecast period, with a significant impact coming from key markets such as China, Japan, and India. The poultry industry in the Asia Pacific has been witnessing growth like never before. As the market for protein-rich foods grows, there has been a consistently increasing demand for poultry meat and eggs. The exports of meat products from these regions are also high. Latin America will also undergo rapid market growth during the forecast period on the grounds of improving awareness and growing demand for food from an ever-growing population.

Periods of History and Forecast

This research report presents the analysis of each segment considered for the period from 2016 to 2026, using 2017 as the base year for estimations. Compounded annual growth rates (CAGRs) for each segment are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The poultry health market report provides a quantitative assessment of the industry in terms of current and forecasted market size while also presenting the market dynamics. This market is segmented based on drugs, diagnostic tools, and geography.

Trends in the global poultry health industry are assessed to understand the current and future outlook of the market. An analysis of the market drivers, challenges, and opportunities gives insights into the positive areas and pain points currently prevalent in the market. This report also includes profiles of key players operating in the global poultry health market. Companies are profiled based on parameters such as their business overview, financial information, product portfolio, and key developments. The key players currently engaged in the global poultry health market are Bayer AG (Bayer Animal Healthcare), Bimeda, Inc., Boehringer Ingelheim Animal Health, Ceva Animal Health, Inc., Eli Lily and Company (Elanco Animal Health), Merck & Company, Inc., Sanofi SA (Merial Animal Health), Virbac SA, Vetoquinol SA, and Zoetis, Inc.

Frequently Asked Questions:

The market for Poultry Health Market is expected to reach US$ 11,506.3 Mn by 2026.

The Poultry Health Market is expected to see significant CAGR growth over the coming years, at 7.1%.

The report is forecasted from 2018-2026.

The base year of this report is 2017.

Bayer AG (Bayer Animal Healthcare), Bimeda, Inc., Boehringer Ingelheim Animal Health, Ceva Animal Health, Inc., Eli Lily and Company (Elanco Animal Health), Merck & Company, Inc., Sanofi SA (Merial Animal Health), Virbac SA, Vetoquinol SA, and Zoetis, Inc. are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  May 2018
Category:  Pharmaceuticals
Report ID:   59185
Report Format:   PDF
Pages:   120
Rating:    4.5 (70)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support